Epidemiological Characteristics and Mortality Risk Factors Comparison in Dialysis and Non-Dialysis CKD Patients with COVID-19-A Single Center Experience
Related Experiment Video
Updated: Sep 6, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Andrei Niculae1,2, Ileana Peride1,2, Ana-Maria Nechita2
1Clinical Department No. 3, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Insights
Chronic kidney disease (CKD) patients face higher COVID-19 mortality risks. Key factors like hemoglobin, creatinine, and age predict adverse outcomes in both non-dialysis and dialysis patients.
Area of Science:
- Nephrology
- Infectious Diseases
- Critical Care Medicine
Background:
- Chronic kidney disease (CKD) is linked to poorer COVID-19 outcomes and increased mortality.
- Inflammatory biomarkers are associated with severe COVID-19 cases.
- CKD patients represent a vulnerable population during the COVID-19 pandemic.
Purpose of the Study:
- To analyze the epidemiological features of COVID-19 in CKD patients.
- To identify parameters influencing mortality risk and severity in COVID-19 infected CKD patients.
- To compare outcomes between non-dialysis and dialysis CKD patients with COVID-19.
Main Methods:
- Retrospective study design.
- Inclusion of 362 non-dialysis and 132 dialysis CKD patients with COVID-19.
- Statistical analysis of demographic, clinical, and inflammatory markers.
Main Results:
- Significant differences observed in age, hemoglobin, interleukin-6, serum albumin, procalcitonin, ferritin, and serum creatinine between groups.
- Higher, though not statistically significant, risk of death in the dialysis group (Exp(b) = 1.839).
- Similar survival proportions were found in both non-dialysis and dialysis groups.
Conclusions:
- High hemoglobin, serum creatinine, and LDH levels at admission are associated with adverse outcomes.
- Advanced age and significant pulmonary impairment (>25%) predict poor prognosis.
- Shorter hospital stays (≤10 days) correlate with adverse outcomes in CKD patients with COVID-19.
Abstract:
(1) Background: Despite some controversies between studies, chronic kidney disease (CKD) has a negative impact on COVID-19 outcomes, with patients presenting a higher mortality risk than in the general population. Studies have shown an association between COVID-19 severe cases and different inflammatory biomarkers. The aim of this study was to emphasize the epidemiological characteristics of CKD patients diagnosed with COVID-19 and to determine if the risk of mortality, and the severity of this infection might be influenced by different parameters. (2) Methods: Our retrospective study included CKD patients with COVID-19—362 in the non-dialysis group and 132 in the dialysis group. (3) Results: There were significant statistical differences between our groups regarding age (p < 0.001), hemoglobin (p < 0.001), interleukin-6 (p < 0.001), serum albumin (p = 0.016), procalcitonin (p = 0.002), ferritin (p < 0.001), and of course serum creatinine (p < 0.001). Even if the risk of death was higher in the dialysis group (Exp(b) = 1.839), the survival proportions were similar in both groups. (4) Conclusions: High values of hemoglobin, serum creatinine, and LDH at admission, age, length of hospital stay ≤ 10 days, and a pulmonary impairment > 25% are responsible for an adverse outcome in non-dialysis and dialysis patients diagnosed with COVID-19.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

